Limited Cytokine Production in Infant CD4 T-Cell Responses After SARS-CoV-2 mRNA Vaccination

Overview

SARS-CoV-2 mRNA vaccination in infants induces significant but limited CD4 T-cell cytokine responses compared to adults, with notable differences influenced by vaccine manufacturer. While infants generate robust spike-specific IgG titers similar to adults, their CD4 T-cell production of key cytokines such as IFN-γ is muted.

Background

mRNA vaccines BNT162b and mRNA-1273 have been adapted for pediatric use to protect infants against COVID-19. Although these vaccines elicit comparable antibody responses in infants and adults, the quality and magnitude of T-cell responses, particularly CD4 T-cell cytokine production, remain less understood in infants. CD4 T-cells play a crucial role in coordinating immune responses and may influence disease severity and viral clearance. Understanding infant T-cell responses is critical given the lower vaccine efficacy observed in young children compared to adults.

Data Highlights

Key Findings

• Infants show significant increases in IL-2 and TNF-α producing CD4 T-cells post SARS-CoV-2 mRNA vaccination, but IFN-γ induction is muted compared to adults.
• Th2 and Th17 cytokine responses are limited in both infants and adults following vaccination.
• Infants vaccinated with mRNA-1273 exhibit greater CD4 T-cell responses than those receiving BNT162b.
• Spike-specific IgG antibody titers post vaccination are comparable between infants and adults despite differences in T-cell cytokine responses.
• The infant vaccine formulations differ in mRNA dose and schedule compared to adult formulations, potentially influencing immune responses.

Clinical Implications

Clinicians should recognize that while SARS-CoV-2 mRNA vaccines elicit strong antibody responses in infants, the cellular immune response, particularly CD4 T-cell cytokine production, is limited and varies by vaccine type. This may contribute to the lower observed vaccine efficacy in young children and underscores the importance of continued monitoring and potentially optimizing vaccine strategies for this population.

Conclusion

Infants vaccinated with SARS-CoV-2 mRNA vaccines develop restricted cytokine-producing CD4 T-cell responses relative to adults, despite similar antibody titers. Vaccine manufacturer and formulation influence these cellular immune responses, highlighting the need for tailored pediatric vaccination approaches.

References

1. Author/Source/Year -- Limited Cytokine Production in Infant CD4 T-Cell Responses Following SARS-CoV-2 mRNA Vaccination Influenced by Vaccine Manufacturer